Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Sep 15;10(6):588-91.
doi: 10.4161/cbt.10.6.13128. Epub 2010 Sep 24.

Driver mutations: a roadmap for getting close and personal in pancreatic cancer

Affiliations
Comment

Driver mutations: a roadmap for getting close and personal in pancreatic cancer

Murray Korc. Cancer Biol Ther. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathways activated by novel driver mutations intersect with Kras driven aberrant signaling pathways in pancreatic cancer cells. In addition to harboring mutated Kras, pancreatic cancer cells overexpress tyrosine kinase receptors, an example of which is shown binding excessive levels of growth factors (GF). This leads to excessive Ras activation even when Kras is not mutated. Ras becomes active downstream of the adapter proteins SHC and GRB2 and the SOS guanine nucleotide exchange factor. There is activation of additional pathways downstream of ras, as described in the text, but only the RAF, MEK, MAPK cascade is shown. PI3K activation leads to PIP3 generation and subsequent AKT and protein kinase C (PKC) epsilon (PKCε) activation, serving to promote cancer cell survival and chemoresistance. Mutated PI3KCG, which encodes a mutated PI3Kγ, may activate aberrant pathways downstream of gastrointestinal hormones such as cholecystokin (CCK) or gastrin, leading to excessive ras activation and PIP3 generation, further promoting cancer cell survival and proliferation. Concomitantly, there is activation of phospholipase C-gamma (PLCγ), which leads to the generation of inositol-1,4,5-trisphosphate (IP3) which mobilizes intracellular calcium and diacylglycerol (DAG), which activates PKC. Mutated DAG kinase (DGKA), STK33 (which exhibits homology with calcium-calmodulin dependent kinase) and PRKCG, which encodes the gamma isoform of PKC, can in theory “join forces” to lead to enhanced cancer cell proliferation and invasion.

Comment on

References

    1. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2:897–909. - PubMed
    1. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437–450. - PubMed
    1. Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 2003;17:3112–3126. - PMC - PubMed
    1. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005;7:469–483. - PubMed
    1. Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, et al. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006;20:3130–3146. - PMC - PubMed

Publication types